Virginia’s pharma manufacturing successes build on years of ecosystem development.

Virginia’s cities, counties, and towns represent a wide range of living situations, with a location to support any lifestyle.

With recent investments in biopharma manufacturing, Virginia is meeting the moment with a major push to build its talent pipeline, launching new training programs and a dedicated workforce center to prepare workers for advanced manufacturing roles. As reshoring accelerates, the Commonwealth is positioning itself not just as a production hub—but as a leader in workforce readiness. 

Merck, Eli Lilly, Astra Zenec and more have made investments to expand in Virginia, signalling a broader surge in U.S.-based biopharma manufacturing as major drugmakers invest billions to bring production stateside. Driven by pandemic-era supply chain risks and new policy incentives, a nationwide reshoring wave is rapidly gaining momentum.

Defense technology company to create 175 new jobs at Reston office

An article in Virginia Business examines how Virginia secured more than $12 billion in major pharmaceutical manufacturing investments in 2025 - attributing the success largely to long-term preparation and partnerships and tailored support.

Automotive Parts Manufacturer to create 60 new jobs in the Commonwealth